• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Central sensitization syndrome may be associated with chronic autonomic concerns

byPaary BalakumarandAlex Chan
May 19, 2025
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
American Academy of Pediatrics recommends standards for adverse event disclosures
Share on FacebookShare on TwitterShare on LinkedIn

1. Central sensitization syndrome is present in most patients with chronic autonomic concerns

2. Patients with central sensitization syndrome reported worse autonomic symptoms despite showing less severe objective autonomic dysfunction

Evidence Rating Level: 2 (Good)

This study investigated the role of central sensitization syndrome (CSS) in patients with chronic autonomic symptoms unexplained by objective testing, hypothesizing that CSS amplifies symptoms through disrupted interoceptive processing. Researchers conducted a retrospective case-control analysis of 555 patients with orthostatic intolerance, assessing autonomic function (Valsalva maneuver, tilt testing, sudomotor evaluation) and patient-reported outcomes (Central Sensitization Inventory [CSI], Compass-31, Neuropathy Total Symptom Score-6). CSS (CSI≥40) was present in 78% of participants, who were predominantly younger females with longer symptom duration and higher rates of comorbidities like fibromyalgia and anxiety compared to non-CSS patients. While both groups showed autonomic failure (AF), CSS patients reported significantly worse symptoms (higher Compass-31 and NTSS-6 scores, strongly correlated with CSI) despite less severe objective AF (mean AF scores 4.21 vs. 5.23, p=0.021). Notably, CSS patients demonstrated greater orthostatic cerebral blood flow decline (p<0.001) and hypocapnia (p=0.004), suggesting central dysregulation contributes to symptom amplification. These findings indicate CSS is prevalent in autonomic dysfunction and may explain symptom-sign discordance, emphasizing the need for dual treatment targeting both CSS and AF. For clinicians, recognizing CSS in patients with disproportionate symptoms can guide more comprehensive management strategies.

Click to read the study in Neurology

Image: PD

RELATED REPORTS

Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy

A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: autonomic dysfunctioncentral sensitization syndromeneurologypainpsychiatry
Previous Post

Taletrectinib in ROS1 mutated Non–Small Cell Lung Cancer

Next Post

Inebilizumab reduces the risk of flares in IgG4-related disease

RelatedReports

A surgical tray with instruments, balanced scales indicating cost, and monetary coins, symbolizing the economics of surgery and complication management.
Gastroenterology

Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy

October 19, 2026
Depiction of a brain with highlighted areas of activity next to a hand reaching towards a pain signal, alongside an MRI machine, suggesting investigation of pain perception mechanisms.
Chronic Disease

A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome

October 18, 2026
A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
Next Post

Inebilizumab reduces the risk of flares in IgG4-related disease

Insulin costs rose exponentially, regardless of formulation or patent

Automated insulin delivery improves glycemic control over continuous glucose monitoring

#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections

#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Zanidatamab-hrii combinations improved survival in first-line HER2-positive advanced gastroesophageal adenocarcinoma
  • Upacicalcet reduced parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism in PATH-1 and PATH-2
  • WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.